Related Experiment Video
Updated: Oct 27, 2025

Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli
Published on: September 25, 2016
[Secondary prevention of ischemic stroke: laboratory and imaging biomarkers]
1Klinik für Neurologie, Universitätsspital Zürich und Universität Zürich.
Insights
Identifying stroke causes is key to preventing recurrence. New laboratory and imaging biomarkers aid in better stroke etiology stratification for improved secondary prevention strategies.
Area of Science:
- Neurology
- Biomarkers
- Stroke Medicine
Background:
- Stroke recurrence is a significant concern, necessitating accurate etiological diagnosis.
- Current etiological classification includes large artery atherosclerosis, cardiac embolism, and small vessel disease.
- Identifying the precise cause of ischemic stroke is crucial for effective secondary prevention.
Purpose of the Study:
- To review current knowledge on laboratory and imaging biomarkers for ischemic stroke secondary prevention.
- To highlight the potential of these biomarkers in clinical stroke patient care.
- To improve the stratification of stroke etiology using novel biomarkers.
Main Methods:
- Literature review of recent studies on biomarkers in stroke secondary prevention.
- Analysis of laboratory and imaging techniques for etiological diagnosis.
- Synthesis of current evidence on biomarker utility in stroke patient management.
Main Results:
- Biomarkers show promise in refining stroke etiological classification.
- Laboratory and imaging biomarkers can aid in stratifying patients based on stroke cause.
- These advancements have the potential to personalize secondary stroke prevention.
Conclusions:
- Biomarkers are increasingly important in understanding and preventing stroke recurrence.
- Further research and clinical integration of biomarkers are needed for optimal stroke care.
- Biomarker-guided secondary prevention strategies are anticipated to improve patient outcomes.
Abstract:
Secondary prevention of ischemic stroke: laboratory and imaging biomarkers Abstract. Identifying the cause of stroke is pivotal to prevent stroke recurrence. Large artery atherosclerosis, cardiac embolism, small vessel disease or other, rarer pathologies can induce ischemic stroke. Recently, laboratory and imaging biomarkers have been proposed to contribute to a better stratification of stroke etiology. This article summarizes current knowledge in the field of biomarkers in secondary prevention of stroke; and highlights the potential for future application in clinical stroke patient care.
More Related Videos
06:45Author Spotlight: Integrated Photoacoustic, Ultrasound, and Angiographic Tomography (PAUSAT) for NonInvasive Whole-Brain Imaging of Ischemic Stroke
Published on: June 2, 2023
09:36A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis
Published on: August 12, 2025
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...